VolitionRx Limited

December 22, 2014December 22, 2014

VolitionRx And University Hospital Bonn Will Test NuQ Technology’s Precision in Lung Cancer Detection

News

VolitionRx Limited has announced that its Nucleosomics platform technology for the diagnosis of lung cancer will be evaluated in a confirmatory clinical study by the University Hospital Bonn in Germany. The Nucleosomics platform ... Read more

December 9, 2014December 9, 2014

Study Proves VolitionRx’s NuQ Test Effective For Lung Cancer Detection in Blood And Sputum

News

VolitionRx Limited will present recent results from its pilot lung cancer study at the Science for Business BioWin Day 2014, in Louvain-la-Neuve, Belgium. Lung cancers are currently diagnosed when patients exhibit symptoms of impaired ... Read more